MaxCyte
is a Maryland-based cell-engineering company that designs and develops electroporation systems for pharmaceutical and biotechnology industries... Read moreMaxCyte
is a Maryland-based cell-engineering company that designs and develops electroporation systems for pharmaceutical and biotechnology industries... Read more
News
May 13, 2026
Seeking Alpha
MaxCyte: MaxCyte outlines $30M-$32M 2026 revenue outlook as board authorizes $10M share repurchase program
May 13, 2026
Nasdaq
MaxCyte: MaxCyte Q1 Earnings Call Highlights
May 12, 2026
Yahoo
MaxCyte: MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
Apr 29, 2026
GlobeNewswire
Press Release: MaxCyte : MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026
Mar 31, 2026
Benzinga
MaxCyte: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 27, 2026
Owler
MaxCyte, Inc.: MaxCyte's employee count changed from 114 in Dec 2024 to 91 in Dec 2025
Mar 25, 2026
Seeking Alpha
MaxCyte: MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript
Mar 25, 2026
Seeking Alpha
MaxCyte: MaxCyte outlines $30M-$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook
Feb 25, 2026
Yahoo
MaxCyte: MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery
Feb 24, 2026
Marketscreener
MaxCyte: MaxCyte, Inc. Unveils Expert DTx, A 96-Well Electroporation Platform to Accelerate Discovery
MaxCyte Competitors
1
2
3
4
5
6
7
8
9
10